Picture of Bioventix logo

BVXP — Bioventix Share Price

gb flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral


Relative Strength (%)
Volume Change (%)
Price vs... (%)
52w High-19.77%
50d MA-3.17%
200d MA+0.15%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)26.74
PEG Ratio (f)20.29
EPS Growth (f)1.34%
Dividend Yield (f)3.62%
Valuation (ttm)IndustryMarket
Price to Book Value18.47
Price to Tang. Book18.47
Price to Free Cashflow27.1
Price to Sales17.12
EV to EBITDA21.38

Shareholder Activity

TypeBuy / Hold / Sell

Guru Screens


Return on Capital81.08%
Return on Equity66.09%
Operating Margin75.64%

Financial Summary

Health Trend(F-Score)


Bankruptcy Score(Z-Score)


Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR

Latest News & Insights for BVXP

Why Bioventix (LON:BVXP) will appeal to moat investors background image

Why Bioventix (LON:BVXP) will appeal to moat investors

There's an exclusive group of companies in the stock market that stand out because they've got what billionaire investor Warren Buffett calls economic moats. Like medieval castles, their profits are fortified by impregnable business mo...

Four clues to the quality of Bioventix (LON:BVXP) background image

Four clues to the quality of Bioventix (LON:BVXP)

Warren Buffett makes it look so easy: find high-quality companies, wait for a fair price to buy, and then hold them... forever. The problem of course is that these stocks are hard to find - but there are signs that Bioventix LON:BVXP c...

Four signs of a competitive moat at Bioventix (LON:BVXP) background image

Four signs of a competitive moat at Bioventix (LON:BVXP)

Given that widespread uncertainty in the economy and the stock market is likely to endure for many months, it pays to know that you're investing in high-quality stocks, rather than speculative ones. This means safe, profitable companie...

Bioventix hits 52w high – but will it continue? background image

Bioventix hits 52w high – but will it continue?

It's a good time to be a shareholder in Bioventix (LON:BVXP): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Shares in Bioventix are currently t...

Bioventix (LON:BVXP): buy, sell or hold? background image

Bioventix (LON:BVXP): buy, sell or hold?

Shares in Bioventix (LON:BVXP) are currently trading close to a 52 week high, with the share price up by around 0.23% - to 4300 - over the past week. On a one-month basis, the Bioventix share price has risen by 6.54%. For investors hol...

Graphical History

Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Bioventix EPS forecast chart

Profile Summary

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The Company offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The Company also supplies antibody products and services to multinational clinical diagnostics companies. The Company sells its products through direct sales and through distributors.


Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
October 7th, 2003
Public Since
April 29th, 2014
No. of Employees
Biotechnology & Medical Research
gb flag iconLondon Stock Exchange
Shares in Issue

BVXP Share Price Performance

Latest News for BVXP

Upcoming Events for BVXP

Full Year 2022 Bioventix PLC Earnings Release

Bioventix PLC Annual Shareholders Meeting

Similar to BVXP

Picture of 4Basebio logo


gb flag iconLondon Stock Exchange

Picture of 4d Pharma logo

4d Pharma

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Picture of Arecor Therapeutics logo

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Avacta logo


gb flag iconLondon Stock Exchange


Or unlock with your email

Or unlock with your email